Can-Fite BioPharma American Depositary Shares
CANF
8 hedge funds and large institutions have $2.66M invested in Can-Fite BioPharma American Depositary Shares in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0% → 0% (+0%)
11% less funds holding
Funds holding: 9 → 8 (-1)
17% less capital invested
Capital invested by funds: $3.2M → $2.66M (-$537K)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$533K |
| 2 |
TAM
Taylor Asset Management
Toronto,
Ontario, Canada
|
+$272K |
| 3 |
MC
Menta Capital
San Francisco,
California
|
+$90.5K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$20.1K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$10.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$362K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$58K |
| 3 |
BG
Bollard Group
Boston,
Massachusetts
|
-$32K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$25K |
| 5 |
Citigroup
New York
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $1.66M | +$272K | +27 | +17% |
|
|
2
Morgan Stanley
New York
| $705K | +$533K | +53 | +189% |
|
|
MC
3
Menta Capital
San Francisco,
California
| $113K | +$90.5K | +9 | +225% |
|
|
4
Jane Street
New York
| $108K | -$362K | -36 | -75% |
|
|
VKH
5
Virtu KCG Holdings
New York
| $52K | +$10.1K | +1 | +20% |
|
|
6
Creative Planning
Overland Park,
Kansas
| $14K | +$20.1K | +2 | New |
|
|
7
Group One Trading
Chicago,
Illinois
| $6K | +$10.1K | +1 | New |
|
|
IA
8
IFP Advisors
Tampa,
Florida
| $4K | +$10.1K | +1 | New |
|
|
MFS
9
MSI Financial Services
Springfield,
Massachusetts
| $3K | – | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$58K | -5 | Closed |
|
|
BG
11
Bollard Group
Boston,
Massachusetts
| – | -$32K | -3 | Closed |
|
|
12
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$25K | -2 | Closed |
|
|
13
Citigroup
New York
| – | -$16K | -1 | Closed |
|
CANF Hedge Fund Activity: Q4 2015 in Review
8 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q4 2015, worth a combined $2.66M — down 17% from $3.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CANF and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.
The largest buyer was Morgan Stanley, adding an estimated $533K. The largest seller was Jane Street, cutting an estimated $362K.
- 8 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q4 2015, down from 9 in Q3 2015.
- Funds reported $2.66M of Can-Fite BioPharma American Depositary Shares stock for Q4 2015, down 17% quarter-over-quarter.
- 3 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q4 2015 and 4 closed out, a net change of -1 holder.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q4 2015 was Morgan Stanley, an estimated $533K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q4 2015 was Jane Street, an estimated $362K sold.
Based on aggregated 13F filings for Q4 2015.